In a regulatory filing, Lupin Ltd announced launch of Posaconazole delayed-release tablets, 100 mg, after its alliance partner AET Pharma US Inc. received an approval for its abbreviated new drug application from USFDA.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2OMgZJl
via IFTTT
0 comments:
Post a Comment